These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 22261393)
1. Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain. Patel AN; Jhamandas JH Expert Rev Mol Med; 2012 Jan; 14():e2. PubMed ID: 22261393 [TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function. Takeda S; Sato N; Rakugi H; Morishita R Mol Biosyst; 2011 Jun; 7(6):1822-7. PubMed ID: 21431241 [TBL] [Abstract][Full Text] [Related]
3. [Involvement of beta-amyloid in the etiology of Alzheimer's disease]. Tomiyama T Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873 [TBL] [Abstract][Full Text] [Related]
4. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease. Lilja AM; Porras O; Storelli E; Nordberg A; Marutle A J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052 [TBL] [Abstract][Full Text] [Related]
5. Neuronal nicotinic acetylcholine receptors serve as sensitive targets that mediate beta-amyloid neurotoxicity. Liu Q; Wu J Acta Pharmacol Sin; 2006 Oct; 27(10):1277-86. PubMed ID: 17007734 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the toxic mechanism triggered by Alzheimer's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cells. Tsukamoto E; Hashimoto Y; Kanekura K; Niikura T; Aiso S; Nishimoto I J Neurosci Res; 2003 Sep; 73(5):627-36. PubMed ID: 12929130 [TBL] [Abstract][Full Text] [Related]
7. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization. De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579 [TBL] [Abstract][Full Text] [Related]
8. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine. Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766 [TBL] [Abstract][Full Text] [Related]
10. Synaptotoxic amyloid-β oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease? Klein WL J Alzheimers Dis; 2013; 33 Suppl 1():S49-65. PubMed ID: 22785404 [TBL] [Abstract][Full Text] [Related]
11. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease? Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267 [TBL] [Abstract][Full Text] [Related]
12. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers. Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339 [TBL] [Abstract][Full Text] [Related]
13. Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein. Kim HJ; Chae SC; Lee DK; Chromy B; Lee SC; Park YC; Klein WL; Krafft GA; Hong ST FASEB J; 2003 Jan; 17(1):118-20. PubMed ID: 12424218 [TBL] [Abstract][Full Text] [Related]
14. β-Amyloid protein (Aβ) and human amylin regulation of apoptotic genes occurs through the amylin receptor. Jhamandas JH; Mactavish D Apoptosis; 2012 Jan; 17(1):37-47. PubMed ID: 21947943 [TBL] [Abstract][Full Text] [Related]
15. The cholinergic system in aging and neuronal degeneration. Schliebs R; Arendt T Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918 [TBL] [Abstract][Full Text] [Related]
16. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors. Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051 [TBL] [Abstract][Full Text] [Related]